8-Hydroxy-xyloguanosine
8-Hydroxy-xyloguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
2390368-04-2
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/8-hydroxy-xyloguanosine.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(N([C@@H]3O[C@H](CO)[C@H](O)[C@H]3O)C(N2)=O)NC(N)=N1
Molecular Formula
C10H13N5O6
Molecular Weight
299.24
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![4,5-Dibromo-1,2,6,7-tertahydro-8H-indeno[5,4-b]furan-8-one](https://cdn.genprice.uk/products/572/3912877494830/imageurl/trc-d425478-50mg.webp)
4,5-Dibromo-1,2,6,7-tertahydro-8H-indeno[5,4-b]furan-8-one
